U.S. flag

An official website of the United States government

Format
Items per page
Sort by

Send to:

Choose Destination

Links from GEO DataSets

Items: 8

1.

Widespread traces of lytic KSHV in primary effusion lymphoma at single-cell resolution

(Submitter supplied) Cancer cells of primary effusion lymphoma (PEL) often contain both Kaposi sarcoma-associated herpesvirus (KSHV) and Epstein-Barr virus (EBV). We measured the interplay of human, KSHV, and EBV transcription in a cell culture model of PEL using single-cell RNA sequencing. The data detect widespread trace expression of lytic KSHV genes.
Organism:
human gammaherpesvirus 4; Homo sapiens; Human gammaherpesvirus 8
Type:
Expression profiling by high throughput sequencing
Platform:
GPL28902
2 Samples
Download data: CSV
Series
Accession:
GSE154900
ID:
200154900
2.

Affymetrix analysis for host cells transcriptome

(Submitter supplied) Analyze possible changes in the transcriptome of host cell line infected with a recombinant EBV virus. The recombinant virus is an Akata cell-derived NeoR EBV strain, previously used in PMID: 12969959
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL570
6 Samples
Download data: CEL
Series
Accession:
GSE121934
ID:
200121934
3.

K1 and K15 of Kaposi sarcoma-associated herpes virus are functional homologues of latent membrane protein 2A of Epstein-Barr virus

(Submitter supplied) LMP2A of Epstein-Barr virus is a receptor that mimics an activated B cell receptor, BCR. K1 and K15, related receptors of Kaposi sarcoma-associated herpes virus, KSHV, are expressed in virus-associated tumors but their functions are less obvious. We addressed this uncertainty with mutant EBVs encoding the KSHV genes K1 or K15 in lieu of LMP2A and infected primary human B cells with them. K1 and K15 encoded proteins appear to have noncomplementing redundant functions in this model but our findings suggest that both KSHV proteins can replace LMP2A’s key activities contributing to the survival, activation and proliferation of B cells.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL6244
16 Samples
Download data: CEL
Series
Accession:
GSE53914
ID:
200053914
4.

RNA sequencing for KSHV circular RNAs

(Submitter supplied) The purpose was to detect viral circular RNAs from infected cells.
Organism:
Homo sapiens; Human gammaherpesvirus 8
Type:
Expression profiling by high throughput sequencing
Platform:
GPL25719
8 Samples
Download data: BED
Series
Accession:
GSE121756
ID:
200121756
5.

Microarray analysis with KSHV infection and enrichment for circular RNAs

(Submitter supplied) The purpose was to measure expression changes in human circular RNAs. Total RNA was harvested from KSHV-infected HUVEC and MC116 cells. A portion of the RNA was digested with RNase R to enrich for circular RNAs.
Organism:
Homo sapiens
Type:
Non-coding RNA profiling by array
Platform:
GPL19977
12 Samples
Download data: GPR
Series
Accession:
GSE120045
ID:
200120045
6.

RNA sequencing with KSHV infection and enrichment for circular RNAs

(Submitter supplied) The purpose was to measure expression changes in human and viral circular RNAs.
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing; Non-coding RNA profiling by high throughput sequencing
Platform:
GPL16791
20 Samples
Download data: TXT
7.

Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: high-resolution mapping of BRD4 binding sites in the KSHV genome

(Submitter supplied) Primary effusion lymphoma (PEL) is an aggressive subtype of non-Hodgkin lymphoma caused by Kaposi's sarcoma-associated herpesvirus (KSHV) infection. Currently, treatment options for patients with PEL are limited. Oncolytic viruses have been engineered as anticancer agents and have recently shown increased therapeutic promise. Similarly, lytic activation of endogenous viruses from latently infected tumor cells can also be applied as a cancer therapy. more...
Organism:
Homo sapiens
Type:
Genome binding/occupancy profiling by high throughput sequencing
Platform:
GPL21290
2 Samples
Download data: TXT
Series
Accession:
GSE103395
ID:
200103395
8.

Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation

(Submitter supplied) Primary effusion lymphoma (PEL) is an aggressive subtype of non-Hodgkin lymphoma caused by Kaposi’s sarcoma-associated herpesvirus infection, which is most commonly seen in HIV-positive patients. Induction of HIV reactivation by external stimuli in the presence of highly active anti-retroviral therapy (HAART) has been examined for its efficacy to eradicate latently infected HIV. Similary, lytic activation of viruses from latently infected tumor cells with anti-cancer drugs represents an effective strategy of anti-neoplastic therapy, through the induction of oncolysis by viral replication, stimulation of immune responses to the viral lytic antigens, and intrinsic effects of cancer drugs. more...
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing
Platform:
GPL20301
12 Samples
Download data: TXT
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

db=gds|term=|query=1|qty=4|blobid=MCID_6622ef004c13c13a063eec1a|ismultiple=true|min_list=5|max_list=20|def_tree=20|def_list=|def_view=|url=/Taxonomy/backend/subset.cgi?|trace_url=/stat?
   Taxonomic Groups  [List]
Tree placeholder
    Top Organisms  [Tree]

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center